Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma.

Details

Language :

English

ISSN :

1073449X

Volume :

188

Issue :

11

Database :

Complementary Index

Journal :

American Journal of Respiratory & Critical Care Medicine

Publication Type :

Academic Journal

Accession number :

94582996

Full Text :

https://doi.org/10.1164/rccm.201212-2318OC